Cambridge Healthtech Institute’s 5th Annual

Leveraging RWD for Clinical and Observational Research

RWD Innovation and Technologies

February 20-21, 2020


The abundance of data generated during routine health care is growing in significance and should be used for clinical and observational research. Patient electronic records, registries, data from pharmacy and social media, and wearable sensors have been increasingly used as eSources. This process requires strategizing, implementing novel data technologies, as well as close collaboration between pharmaceutical companies and organizations that possess the data. CHI’s 5th Annual Leveraging RWD for Clinical and Observational Research conference will discuss innovative approaches and technologies for RWD-based clinical and observational studies.

Arrive early and attend Part 1 (Wed - Thurs): Accessing and Generating RWD

Preliminary Agenda

INNOVATIVE RWD-BASED STUDIES

Hybrid Approaches for Data Collection in RWD

Charles Makin, Global Head, Real World Evidence Strategy, Biogen

Transparent and Replicable ‘Real-World’ Evidence from ‘Real-World’ Data

Shirley Wang, PhD, Assistant Professor, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

RWD TO SUPPLEMENT RCT

Real-World Evidence Complements and Supplements Clinical Trial Designs

David Van Brunt, PhD, Senior Research Fellow and Head, HEOR Division of Evidence and Analytics AbbVie, Inc.

External Control Arms for Trial Development

T. Kim Le, Group Director, Center for Observational Research & Data Sciences (CORDS), Business Insights & Analytics, Bristol-Myers Squibb

How to Use RWD to Optimize Eligibility Criteria and Enhance Recruitment

Jack Sheehan, RPh, MBA, PhD, Director, Real-World Value and Evidence, Neuroscience, Janssen Scientific Affairs (JSA)

PLENARY KEYNOTES

Tuesday Evening, Wednesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:

SCOPE’s 2020 Participant Engagement Award, in Memory of Jerry Matczak
Patient Perspectives as an Input to Feasibility and Clinical Trial Design
Digital Trends that Are Changing Clinical Research
Health Literacy Throughout Drug Development – Why It Matters to Pharma and to Patients
Implementing an Innovation Methodology to Accelerate Clinical Trial Innovation within Your Organization

For more details on the Plenary Keynotes: www.scopesummit.com/keynotes
For more details on the Participant Engagement Award: www.scopesummit.com/participant-engagement-award

INTERACTIVE BREAKOUT DISCUSSION GROUPS

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing: www.scopesummit.com/breakouts

 

Arrive early and attend Part 1 (Wed - Thurs): Accessing and Generating RWD




For more details on the conference, please contact:
Marina Filshtinsky, MD

Executive Director, Conferences

Cambridge Healthtech Institute

Phone: (+1) 781.972.5496

Email: mfilshtinsky@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Ilana Quigley

Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.5457

Email: iquigley@healthtech.com

 

Companies L-Z

Patty Rose
Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.1349
Email: prose@healthtech.com